Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer

NCT03098836 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: ARN-509
DRUG: Abiraterone Acetate
DRUG: Prednisone

Sponsor

Daniel George, MD

Collaborators

[object Object]